Immunometabolism is a key factor for the persistent spontaneous elite control of HIV-1 infectionLaura Tarancón‐Díez, Francesc Vidal, Manuel Leal et al.|EBioMedicine|2019Cited by 81
Pharmacogenetics of adverse effects due to antiretroviral drugs.Francesc Vidal, Peré Domingo, Félix Gutiérrez et al.|PubMed|2010Cited by 47
A baseline metabolomic signature is associated with immunological CD4+ T-cell recovery after 36 months of antiretroviral therapy in HIV-infected patientsEsther Rodríguez‐Gallego, Francesc Vidal, Josep Gómez et al.|AIDS|2017Cited by 42
Proximal tubular kidney damage and tenofovirMaría Saumoy, Cristóbal Richart, Francesc Vidal et al.|AIDS|2004Cited by 36
Spanish HIV-1-Infected Long-Term Nonprogressors of More Than 15 Years Have an Increased Frequency of the CX3CR1 249I Variant AlleleFrancesc Vidal, S. Mallal, Consuelo Viladés et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2005Cited by 34